Inhibitory effect of the coffee diterpene kahweol on carrageenan-induced inflammation in rats

BioFactors

Volumn 26, Issue 1, 2006, Pages 17-28

  Kim, Ji Young ^a   Dong, Hee Kim ^b   Hye, Gwang Jeong ^a  

^a Chosun University   (South Korea)

^b Daejeon University   (South Korea)

Author keywords

Air pouch; Anti inflammation; Carrageenan; Kahweol; Paw edema

Indexed keywords

ANTIINFLAMMATORY AGENT; CARRAGEENAN; CYCLOOXYGENASE 2; DITERPENE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KAHWEOL; NITRITE; PROSTAGLANDIN E2; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COFFEE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; DRUG EFFECT; EXUDATE; HISTOLOGY; IMMUNOBLOTTING; INFLAMMATION; LEUKOCYTE COUNT; MALE; NEUTROPHIL COUNT; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE;

AIR; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CELL COUNT; COFFEE; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DITERPENES; EDEMA; ENZYME INHIBITORS; EXUDATES AND TRANSUDATES; FOOT; INFLAMMATION; MALE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 33645715637     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520260103     Document Type: Article

References (31)

1. S. Arias-Negrete, K. Keller and K. Chadee, Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages, Biochem. Biophys. Res. Commun. 208 (1995), 582-589.
2. M. Baggiolii, B. Dewald and B. Moser, Chemokines, in: Inflammation. Basic Principle and Clinical Correlates, (3rd ed.), J.I. Gallin and R. Snyderman, eds, Lippincott Williams and Wilkins Press, Philadelphia, 1999, pp. 419-431.
3. F. Bellisle, A.T. Diplock, G. Hornstra, B. Koletzko, M. Roberfroid, S. Salminen and W.H.M. Saris, Functional food in Europe, Br. J. Nutr. 80 (1998), S1-S193.
4. C. Cavin, D. Holzhaeuser, G. Scharf, A. Constable, W.W. Huber and B. Schilter, Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity, Food Chem. Toxicol. 40 (2002), 1155-1163.
5. C. Cavin, K. Mace, E.A. Offord and B. Schilter, Protective effects of coffee diterpenes against aflatoxin BI-induced genotoxicity: Mechanisms in rat and human cells, Food Chem. Toxicol. 39 (2001), 549-556.
6. J.R. Connor, P.T. Manning, S.L. Settle, W.M. Moore, G.M. Jerome, P.K. Webber, F.S. Tjoeng and M.G. Currie, Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase, Eur. J. Pharmacol. 273 (1995), 15-24.
7. B. De Roos, J.K. Sawyer, M.B. Katan and L.L. Rudel, Validity of animal models for the cholesterol-raising effects of coffee diterpenes in human subjects, Proc. Nutr. Soc. 58 (1999), 551-557.
8. E. Giovannucci, Meta-analysis of coffee consumption and risk of colorectal cancer, Am. J. Epidemiol. 147 (1998), 1043-1052.
9. R.J. Griffiths, Prostaglandins and inflammation, in: Inflammation. Basic Principle and Clinical Correlates, (3rd ed.), J.I. Gallin and R. Snyderman, eds, Lippincott Williams and Wilkins Press, Philadelphia, 1999, pp. 349-360.
10. G. Gross, E. Jaccaud and A.C. Huggett, Analysis of the content of the diterpenes cafestol and kahweol in coffee brews, Food Chem. Toxicol. 35 (1997), 547-554.
11. W.R. Henderson, The role of leukotrienes in inflammation, Ann. Intern. Med. 121 (1994), 684-697.
12. W.W. Huber, G. Scharf, W. Rossmanith, S. Prustomersky, B. GraslKraupp, B. Peter, R.J. Turesky and R. Schulte-Hermann, The coffee components kahweol and cafestol induce γ-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat, Arch. Toxicol. 75 (2002), 685-694.
13. W.W. Huber, L.P. McDaniel, K.R. Kaderlik, C.H. Teitel, N.P. Eang and F.F. Kadlubar, Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2amino- 1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP) in the rat, Mutat. Res. 376 (1997), 115-122.
14. H.G. Jeong and J.Y. Kim, Induction of inducible nitric oxide synthase expression by 18beta-glycyrrhetinic acid in macrophages, FEBS Lett. 513 (2002), 208-212.
15. R.Y. Kang, J. Freire-Moar, E. Sigal and C.Q. Chu, Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis, Br. J. Rheumatol. 35 (1996), 711-718.
16. H. Kaur and B. Halliwell, Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients, FEBS Lett. 350 (1994), 9-12.
17. J.Y.Kim, K.S. Jung and H.G. Jeong, Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages, FEBS Lett. 569 (2004), 321-326.
18. J.Y. Kim, K.S. Jung, K.J. Lee, H.K. Na, H.K. Chun, Y.H. Kho and H.G. Jeong, The coffee diterpene kahweol suppress the inducible nitric oxide synthase expression in macrophages, Cancer Lett. 213 (2004), 147-154.
19. G. Kollias, E. Douni, G. Kassiotis and D. Kontoyiarmis, The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease, Ann. Rheum. Dis. 58 (1999), 132-139.
20. J. MacMicking, Q.W. Xie and C. Nathan, Nitric oxide and macrophage function, Annu. Rev. Immunol. 15 (1997), 323-350.
21. H. Maeda and T. Akaike, Nitric oxide and oxygen radicals in infection, inflammation, and cancer, Biochemistry 63 (1998), 854-865.
22. J. Marcinkiewicz, A. Grabowska and B. Chain, Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages, Eur. J. Immunol. 25 (1995), 947-951.
23. J.L. Masferrer, B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson and K. Seibert, Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and non-ulcerogenic, Proc. Natl. Acad. Sci. USA 91 (1994), 3228-3232.
24. D. Salvemini, P.T. Manning, B.S. Zweifel, K. Seibert, J. Connor, M.G. Currie, P. Needleman and J.L. Masferrer, Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors, J. Clin. Invest. 96 (1995), 301-308.
25. D. Salvemini, T.P. Misko, J.L. Masferrer, K. Seibert, M.G. Currie and P. Needleman, Nitric oxide activates cyclooxygenase enzymes, Proc. Natl. Acad. Sci. USA 90 (1993), 7240-7244.
26. K. Seibert, Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, W. Perkins, L. Lee and P. Isakson, Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain, Proc. Natl Acad. Sci. USA 91 (1994), 12013-12017.
27. L.S. Simon, Role and regulation of cyclooxygenase-2 during inflammation, Am. J. Med. 106 (1999), 37S-42S.
28. M. Stefanovic-Racic, J. Stadler and C.H. Evans, Nitric oxide and arthritis, Arthritis Rheum. 36 (1993), 1036-1044.
29. X. Tao, L. Ma, Y. Mao and P.E. Lipsky, Suppression of carrageenan-induced inflammation in vivo by an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F, Inflamm. Res. 48 (1999), 139-148.
30. J.R. Vane, J.A. Mitchell, L. Appleton, A. Tomlison, D. Bishop-Bailey, J. Croxtall and D.A. Willoughby, Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation, Proc. Natl. Acad. Sci. USA 91 (1994), 2046-2050.
31. J.L. Wallace, K. Chapman and W. Mcknigh, Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation, Br. J. Pharmacol. 126 (1999), 1200-1204.